Reproxalap

Reproxalap Uses, Dosage, Side Effects, Food Interaction and all others data.

Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.

Trade Name	Reproxalap
Generic	Reproxalap
Reproxalap Other Names	ADX 102, ADX102, ALD-102, NS-2, Reproxalap
Type
Formula	C12H13ClN2O
Weight	Average: 236.7 Monoisotopic: 236.0716407
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

How Reproxalap works

Reproxalap inhibits Reactive Aldehyde Species (RASP) and is being investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome.

Innovators Monograph

You find simplified version here Reproxalap